Morris Silverman - DiaSys Chairman of the Board, CFO

Chairman

Morris Silverman has served as the Chairman of the Company Board of Directors since November 2002. Effective October 1, 2007, Mr. Silverman was appointed Chief Financial Officer of the Company. Since 1977, Mr. Silverman is the majority owner and Chairman of the Board of M.S. Management Corporationrationration, a private finance company with over 250 branches nationwide. Mr. Silverman has several years of experience in strategic planning and operations within and outside the medical community. He served as the Chairman of Medical Financial Services, Inc., an accounting and receivable financing company for the medical profession from 1975 to 1985. Prior thereto, Mr. Silverman served as Vice President of Operations for Petrie Stories, a New York Stock Exchange company. since 2007.
Age 92
Tenure 17 years
Phone203-755-5083

DiaSys Management Efficiency

The company has return on total asset (ROA) of (0.1778) % which means that it has lost $0.1778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9491) %, meaning that it created substantial loss on money invested by shareholders. DiaSys' management efficiency ratios could be used to measure how well DiaSys manages its routine affairs as well as how well it operates its assets and liabilities.
DiaSys currently holds 645.64 K in liabilities with Debt to Equity (D/E) ratio of 1.05, which is about average as compared to similar companies. DiaSys has a current ratio of 0.34, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about DiaSys' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 6 records

CHAIRMAN Age

Alexander WynaendtsAegon NV ADR
59
William ConnellyAegon NV ADR
63
Corien WortmannKoolAegon NV ADR
62
Cynthia EganThe Hanover Insurance
66
David SimonSimon Property Group
62
Herbert SimonSimon Property Group
86
DiaSys Corporation designs, develops, manufactures, and distributes proprietary medical laboratory equipment, consumables, and test kits to healthcare and veterinary diagnostic laboratories worldwide. The company was founded in 1992 and is based in Waterbury, Connecticut. Diasys Corp is traded on OTC Exchange in the United States. DiaSys (DYXC) is traded on OTCCE Exchange in USA and employs 10 people.

Management Performance

DiaSys Leadership Team

Elected by the shareholders, the DiaSys' board of directors comprises two types of representatives: DiaSys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DiaSys. The board's role is to monitor DiaSys' management team and ensure that shareholders' interests are well served. DiaSys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DiaSys' outside directors are responsible for providing unbiased perspectives on the board's policies.
Frederic Neikrug, President Interim CEO
Morris Silverman, Chairman of the Board, CFO
Robert Wigoda, Secretary, Director
Conard Shelnut, Corporate CoFounder

DiaSys Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DiaSys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in DiaSys Stock

If you are still planning to invest in DiaSys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DiaSys' history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume